USD 65.60 billion
Leukapheresis Market Size, Share, Growth Analysis, By Product Type(Leukapheresis devices and leukapheresis disposables), By Application(Leukemia, lymphoma, and graft-versus-host disease), By End user(Hospitals and blood component centers, pharmaceutical and biotechnology companies, and research institutes), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35B2173 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
88
|Figures:
76
Leukapheresis Market Insights
Leukapheresis Market size was valued at USD 71.44 billion in 2022 and is poised to grow from USD 77.79 billion in 2023 to USD 153.88 billion by 2031, growing at a CAGR of 8.9% during the forecast period (2024-2031).
Global Leukapheresis Market is a vital and rapidly expanding sector within the medical industry, offering critical therapeutic and diagnostic solutions for various diseases. Leukapheresis involves the selective separation and collection of white blood cells (leukocytes) from the blood, enabling their use in treatments, research, and diagnostics. The purpose of the leukapheresis market is to provide healthcare professionals with a valuable tool for the management and treatment of diseases that involve abnormal white blood cell counts or activities. This includes conditions such as leukemia, lymphoma, autoimmune disorders, and certain neurological diseases. Leukapheresis procedures allow for the removal of excessive or malfunctioning white blood cells while preserving other components of the blood, thereby helping to restore a healthier balance.
The market is driven by several factors. Firstly, the increasing prevalence of hematologic disorders and autoimmune diseases has heightened the demand for leukapheresis procedures. According to research, the global incidence of blood cancers and autoimmune disorders has been steadily rising, necessitating effective treatment approaches such as leukapheresis. Moreover, advancements in leukapheresis technologies and techniques have enhanced the safety and efficacy of the procedure, further fueling market growth. Innovative automated systems and improved apheresis machines enable better control, precision, and scalability, making leukapheresis a reliable and widely applicable therapy.
However, the leukapheresis market also faces certain restraints. Limited awareness among healthcare providers and patients about the potential benefits of leukapheresis procedures could hinder market growth. Additionally, the high cost associated with leukapheresis devices and consumables, along with the requirement for specialized healthcare personnel, may limit accessibility, particularly in developing regions. Key trends in the leukapheresis market include the development of personalized medicine approaches and the integration of leukapheresis with other therapies. Personalized medicine aims to tailor treatments to individual patients based on their specific disease characteristics, and leukapheresis plays a crucial role in obtaining patient-specific samples for diagnostics and research.
Furthermore, there are significant opportunities in the leukapheresis market. The increasing research and development activities in the field of immunotherapy and cell-based therapies offer promising avenues for leukapheresis. These therapies, such as chimeric antigen receptor (CAR) T-cell therapy, rely on the collection and manipulation of patient-derived white blood cells, making leukapheresis a vital component in their implementation. Additionally, the growing focus on precision medicine, advancements in apheresis technology, and expanding healthcare infrastructure in developing regions present opportunities for market expansion. Market players can leverage these opportunities by investing in research, raising awareness, and developing cost-effective leukapheresis solutions that meet the specific needs of different patient populations.
US Leukapheresis Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Leukapheresis devices
Fastest Growth
Leukapheresis devices
Growth Rate
8.9% CAGR
Global Leukapheresis Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Leukapheresis Market Segmental Analysis
Global Leukapheresis Market is segmented on the basis of product type, application, end user, and region. By product type, the market is segmented into Leukapheresis devices and leukapheresis disposables. By application, the market is segmented into Leukemia, lymphoma, and graft-versus-host disease. By end user, the market is segmented into hospitals and blood component centers, pharmaceutical and biotechnology companies, and research institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Leukapheresis Market Analysis By Product Type
Leukapheresis devices represent the largest segment in the market due to their crucial role in performing the leukapheresis procedure. These devices are sophisticated instruments that enable the separation and collection of white blood cells from the blood. They incorporate advanced technology, including centrifugation or filtration mechanisms, to selectively extract and preserve the desired cellular components. The significant market share of leukapheresis devices can be attributed to their essentiality in therapeutic and research applications. These devices are extensively used in the treatment of hematologic disorders, such as leukemia and lymphoma, where the removal of abnormal white blood cells is vital for disease management. Furthermore, leukapheresis devices find utility in the collection of specific white blood cell subsets for various research purposes, including cell-based therapies and immunological studies.
On the other hand, the leukapheresis disposables segment is the fastest-growing segment in the market. Leukapheresis dispo sables encompass a range of single-use consumables, such as tubing sets, collection bags, filters, and other associated components, that are utilized during the leukapheresis procedure. These disposables are designed to ensure sterility, safety, and efficient cell collection. The growth of the leukapheresis disposables segment can be attributed to several factors. Firstly, the increasing adoption of leukapheresis procedures in both clinical and research settings has resulted in a higher demand for disposable components. As leukapheresis is performed on a patient-specific basis, the use of single-use disposables eliminates the risk of cross-contamination and ensures optimal hygiene standards.
Leukapheresis Market Analysis By End User
Among these segments, the largest segment is hospitals and blood component centers. Hospitals and blood component centers play a pivotal role in the diagnosis, treatment, and management of various hematologic disorders and autoimmune diseases. They serve as primary healthcare facilities where leukapheresis procedures are performed to collect and process white blood cells for therapeutic or diagnostic purposes. The largest market share of hospitals and blood component centers can be attributed to several factors. Firstly, hospitals are the primary care providers for patients with hematologic disorders, providing comprehensive medical services and treatments. They have the infrastructure, trained personnel, and equipment necessary to conduct leukapheresis procedures efficiently.
On the other hand, the fastest-growing segment in the leukapheresis market is pharmaceutical and biotechnology companies. These companies are increasingly investing in research and development activities to develop novel therapeutic approaches, including cell-based therapies and immunotherapies, which require the use of leukapheresis for cell collection and processing. Pharmaceutical and biotechnology companies are at the forefront of developing cutting-edge treatments for hematologic disorders and autoimmune diseases. They collaborate with hospitals, research institutes, and clinical trial centers to conduct studies and trials that involve leukapheresis procedures. These companies contribute significantly to the advancements in leukapheresis technology, driving the market's growth.
Global Leukapheresis Market By Product Type
To get detailed analysis on other segments, Request For Free Sample Report
Leukapheresis Market Regional Insights
North America dominated the global leukapheresis market, driven by advanced healthcare infrastructure, strong research and development capabilities, and high adoption of innovative medical technologies. The region benefits from the presence of key market players, academic institutions, and research centers focused on advancing leukapheresis procedures. For instance, the United States dominates the North American market with a considerable market share. The country's well-established healthcare system, supportive regulatory environment, and increasing prevalence of hematologic disorders contribute to the market's dominance. Another dominating region is Europe, which holds a significant market share in the global leukapheresis market. European countries such as Germany, France, and the United Kingdom have well-developed healthcare systems and robust research activities. These countries have a high adoption rate of advanced medical technologies and a strong focus on precision medicine, which drives the demand for leukapheresis procedures.
On the other hand, the Asia-Pacific region is the fastest growing region in the global leukapheresis market, offering immense growth potential. Rapid urbanization, increasing healthcare expenditure, and a rising patient population with hematologic disorders and autoimmune diseases contribute to the region's growth. Additionally, countries like China, India, and Japan are investing in healthcare infrastructure development and are witnessing a growing focus on personalized medicine and advanced therapies. For example, China's healthcare sector is rapidly evolving, and the country has a significant patient population that could benefit from leukapheresis procedures. The government's initiatives to improve healthcare access and affordability, coupled with the growing prevalence of blood cancers and autoimmune disorders, present substantial growth opportunities in the Chinese leukapheresis market.
Global Leukapheresis Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Leukapheresis Market Dynamics
Leukapheresis Market Drivers
Increasing Prevalence of Hematologic Disorders
- The rising incidence of hematologic disorders, such as leukemia and lymphoma, is a significant driver for the leukapheresis market. These diseases require effective treatment approaches, and leukapheresis plays a crucial role in managing abnormal white blood cell counts. For example, in cases of acute leukemia, leukapheresis can rapidly reduce the number of leukemic cells in the blood to alleviate symptoms and prepare patients for subsequent therapies.
Leukapheresis Market Restraints
Limited Awareness and Accessibility
- Limited awareness among healthcare providers and patients about the potential benefits of leukapheresis procedures can restrain market growth. Education and awareness programs are necessary to increase understanding and promote the adoption of leukapheresis as a therapeutic option. Moreover, the high cost of leukapheresis devices and consumables, along with the need for trained healthcare professionals, can hinder accessibility, particularly in resource-constrained settings.
Request Free Customization of this report to help us to meet your business objectives.
Leukapheresis Market Competitive Landscape
Global Leukapheresis Market features a highly competitive landscape with the presence of several key players striving to gain a larger market share. Companies in this market are focused on product development, strategic collaborations, mergers and acquisitions, and geographic expansion to strengthen their position in the market. Some prominent players in the leukapheresis market are consistently investing in research and development activities to introduce innovative leukapheresis products and technologies. They are also engaged in partnerships and collaborations with healthcare institutions and research organizations to further expand their product offerings and explore new market opportunities. With the increasing prevalence of blood-related disorders and the rising demand for leukapheresis procedures, the competitive landscape of the global leukapheresis market is expected to witness further advancements and intense competition among the key market players.
Leukapheresis Market Top Player’s Company Profiles
- Haemonetics Corporation (US)
- Macopharma SA (France)
- Miltenyi Biotec GmbH (Germany)
- STEMCELL Technologies Inc. (Canada)
- Cytiva (US)
- Beijing ZKSK Technology Co., Ltd. (China)
- Grifols, S.A. (Spain)
- Kaneka Corporation (Japan)
- Medica SpA (Italy)
- B. Braun Melsungen AG (Germany)
- Immucor, Inc. (US)
- Bioelettronica S.r.l. (Italy)
- Fresenius Kabi AG (Germany)
- Qingdao Huarui Biological Technology Co., Ltd. (China)
- Miltenyi Biotec B.V. & Co. KG (Netherlands)
- Therakos, Inc. (US)
- Pluristem Therapeutics Inc. (Israel)
Leukapheresis Market Recent Developments
- In March 2023, Haemonetics Corporation, headquartered in the United States, made an exciting announcement regarding the release of their latest innovation in the form of intelligent control software for their Cell Saver Elite and Autotransfusion services. This next-generation software represents a significant advancement in their technology, offering enhanced capabilities and functionalities for efficient blood cell processing and transfusion procedures.
- In June 2022, Asahi Kasei Medical, a leading medical company based in Japan, successfully completed the acquisition of Bionova Scientific LLC, a reputable biopharmaceutical Contract Development and Manufacturing Organization (CDMO) based in the United States. This strategic acquisition strengthens Asahi Kasei Medical's presence and capabilities in the biopharmaceutical sector, expanding its portfolio of services and facilitating its ability to provide comprehensive solutions to its global clientele.
Leukapheresis Key Market Trends
- Integration of Leukapheresis with Cell-Based Therapies: Leukapheresis is increasingly integrated with cell-based therapies, such as chimeric antigen receptor (CAR) T-cell therapy. CAR T-cell therapy involves the collection and genetic modification of a patient's own white blood cells, which are then infused back into the patient to target and eliminate cancer cells. Leukapheresis plays a vital role in obtaining the required cells for CAR T-cell therapy, making it an integral part of the treatment process.
Leukapheresis Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Component types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our Global Leukapheresis Market analysis, the global market is expected to experience significant growth in the coming years. The market is driven by factors such as the increasing prevalence of hematologic disorders and autoimmune diseases, advancements in leukapheresis technologies, and the rising adoption of personalized medicine approaches. Additionally, the integration of leukapheresis with cell-based therapies and immunotherapy treatments provides promising opportunities for market expansion. However, limited awareness and high costs associated with leukapheresis procedures could pose challenges to market growth. Nonetheless, with continued research and development efforts, along with strategic investments, the leukapheresis market is poised to witness substantial growth and contribute to improving patient care and disease management globally.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 71.44 billion |
| Market size value in 2031 | USD 153.88 billion |
| Growth Rate | 8.9% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Leukapheresis Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Leukapheresis Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Leukapheresis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Leukapheresis Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Leukapheresis Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Leukapheresis Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
